Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Open-Label Study to Evaluate the Safety and Observe the Effectiveness of 16 Weeks of Alefacept in Palmar Plantar Pustulosis (IST 92)

NCT00301002 is registered in ClinicalTrials.gov with The Guenther Dermatology Research Centre as lead sponsor.

NCT NCT00301002
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00301002 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Open-Label Study to Evaluate the Safety and Observe the Effectiveness of 16 Weeks of Alefacept in Palmar Plantar Pustulosis (IST 92)
Lead sponsor
The Guenther Dermatology Research Centre
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2005
Completion date
October 31, 2006
Enrollment
15
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

palmoplantaris pustulosis, psoriasis, pustular psoriasis of palms and soles, pustulosis of palms and soles, pustulosis palmaris et plantaris